Over the past 25 years, Quantel Medical has been involved in developing and providing state-of-the-art technologies for the diagnosis and treatment of the four major causes of blindness: cataract, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy (DR).
IPL System
* Not FDA Approved
- Dry eye treatment: Meibomian Glands Dysfunction (MGD) and inflammation (rosacea & blepharitis)
- Safe, effective and long-lasting treatment
- Simple and fast treatment (<5 min)
- Treatment on a wide range of skin types thanks to the optimized technical characteristics (train of pulses, filter at 610nm, cooling system).
CLINICAL BENEFITS:
- Improved tear film quality and symptoms
- Optimize post-surgical results by diagnosing and treating before surgery (refractive, cataract)
- Improve the compliance of patients under topical treatment
- Improve the comfort of contact lens wearer
Not Available
-
BIBLIOGRAPHY
-
Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction
-
Neurotransmitter Influence on Human Meibomian Gland Epithelial Cells
-
Update on the management of rosacea
-
Vasoactive Intestinal Polypeptide and the Innervation of the Human Lacrimal Gland
-
Rosacea: Epidemiology, pathogenesis, and treatment
-
Parasympathetic Innervation of the Meibomian Glands in Rats
-
The Ocular Surface
-
PROMOTIONAL VIDEO
Lacrystim - Treatment of dry eye
INTERVIEW
Interview of Dr. Trone: Dry Eye Treatment with Lacrystim
SYMPOSIUM
SFO 2019 - Light on a new dry eye therapy
STANDARD ACCESSORIES:
Patient Protection Shells
Practitioner Protective Goggles
